Research Article

Term Pregnancy Woman with Human Immunodeficiency Virus Infection and Antiretroviral Therapy as Risk Factor of High Caspase-3 Expression in Placenta

Denni Prasetyo
Sanglah General Hospital, Indonesia
* Corresponding author
I Wayan Artana Putra
Sanglah General Hospital, Indonesia
Tjokorda G. A. Suwardewa
Sanglah General Hospital, Indonesia
I Nyoman Hariyasa Sanjaya
Sanglah General Hospital, Indonesia
Anom Suardika
Sanglah General Hospital, Indonesia
I Gde Sastra Winata
Sanglah General Hospital, Indonesia
DOI icon 10.24018/ejmed.2022.4.3.1324

Read Counter
562

Downloads
351

Citations

Share

Article Sidebar

Submitted 2022-04-09
Published 2022-05-17

Read counter = 562 times

Table of Contents

Article Main Content

Aim: To determine whether term pregnant women with human immunodeficiency virus infection who received antiretroviral therapy have a high Caspase-3 expression in the placenta.

Methods: This cross-sectional analytical study was conducted at Sanglah General Hospital, Denpasar, and affiliated hospitals. Subjects were termed pregnant women with HIV (+) who received a minimum of six months of antiretroviral therapy as a risk group and pregnant women with HIV (-) as a non-risk group. Caspase-3 expression was assessed by immunohistochemical examination of placental tissue. The cut-off value for caspase-3 levels was determined by constructing a receiver operating characteristics (ROC) curve. The difference in proportion was assessed by the chi-square test, and the prevalence ratio (PR) was reported. The significance of this study was p<0.05.

Results: Each 20 pregnant women were included in the risk and no-risk groups. There was no difference in age, gestational age, parity, and body mass index (BMI) between the two groups. The mean expression of caspase-3 was significantly higher HIV (+) group than in the HIV (-) group (162.62 vs. 105.83; p = 0.000). The selected cut-off value of Caspase-3 was 127.05, with a sensitivity of 75% and a specificity of 75%. After classification, a significantly higher proportion of Caspase-3 expression was found in the HIV (+) group than in the HIV (-) group (75% vs. 25%; p=0.002). Pregnant women with HIV (+) and receiving antiretroviral therapy for a minimum of six months had a three times higher chance of having a high Caspase-3 prevalence than pregnant women who were not (RP=3.0; 95% CI = 1.348 – 6.678).

Conclusion: Pregnant women with HIV infection who received antiretroviral therapy have a high Caspase-3 expression in the placenta.

Keywords: Antiretroviral therapy, Caspase-3, human immunodeficiency virus, term pregnancy

References

  1. Stover J, Glaubius R, Teng Y, Kelly S, Brown T, Hallett TB, et al. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030. PLoS Med. 2021; 18(10): e1003831.
    DOI  |   Google Scholar
  2. Badru O, Dairo MD, Oladokun RE. Quality of Life of HIV Infected Children Attending the Antiretroviral Clinic, University College Hospital, Ibadan. West Afr J Med. 2020; 37(5): 521-527.
     Google Scholar
  3. Ekouevi DK, Stringer E, Coetzee D, Tih P, Creek T, Stinson K, et al. Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study. PLoS One. 2012; 7(1): e29823.
    DOI  |   Google Scholar
  4. Bailey H, Zash R, Rasi V, Thorne, C. HIV treatment in pregnancy. The Lancet HIV, 2018; 5(8): e457-e467.
    DOI  |   Google Scholar
  5. Agata K, Anita S, Urszula K, Agnieszka N, Grzegorz B. Expression of caspase-3, Bax nad Bcl-2 in placentas from pregnancies complicated by treated and non-treated fetal growth restriction. Ginekologia polska, 2009; 80(9): 652-6.
     Google Scholar
  6. Dadhwal V, Sharma A, Khoiwal K, Deka D, Sarkar P, Vanamail P. Pregnancy Outcomes in HIV-Infected Women: Experience from a Tertiary Care Center in India. Int J MCH AIDS. 2017; 6(1): 75-81.
    DOI  |   Google Scholar
  7. Lopez M, Figueras F, Hernandez S, Lonca M, Garcia R, Palacio M, et al. Association of HIV infection with spontaneous and iatrogenic preterm delivery. AIDS, 2012; 26(1): 37-4.
    DOI  |   Google Scholar
  8. Gurugubelli KR, Vishnu BB. Molecular mechanisms of intrauterine growth restriction. J Matern Fetal Neonatal Med. 2018; 31(19): 2634-2640.
    DOI  |   Google Scholar
  9. Garg H, Mohl J, Joshi A. HIV-1 induced bystander apoptosis. Viruses. 2012; 4(11): 3020-3043.
    DOI  |   Google Scholar
  10. White M, McArthur K, Metcalf D, Lane R, Cambier J, Herold M, et al. Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production. Cell. 2014; 159(7): 1549-1562.
    DOI  |   Google Scholar
  11. Money D, Wagner E, Maan E, Chaworth-Musters T, Gadawski I, van Schalkwyk J, et al. Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women. Plos One. 2015; 10(8): e0135041.
    DOI  |   Google Scholar
  12. Morén C, Noguera-Julián A, Garrabou G. Mitochondrial disturbances in HIV pregnancies. AIDS; 2015; 29: 5-12.
    DOI  |   Google Scholar
  13. Negara IKS, Anantasika AAN, Puta A, Wiradnyana A, Tunas I. Characteristics of pregnant women with HIV infection following prevention of mother to child transmission of HIV (PMTCT) program in Sanglah general hospital 2005-2014. Bali Med J. 2016; 5(1): 147-151.
    DOI  |   Google Scholar
  14. Hernandez S, Garcia MC, Moren C. Placental mitochondrial toxicity, oxidative stress, apoptosis, and adverse perinatal outcomes in HIV pregnancies under antiretroviral treatment containing zidovudine. J Acquir Immune Defic Syndr. 2017; 75: e113-e119.
    DOI  |   Google Scholar
  15. Hung TC, Lu LC, Lin MH, Hu YC, Cheng CY, Cheng SH, et al. Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: a case-control study. J Infect Dev Ctries. 2020; 14(8): 901-907.
    DOI  |   Google Scholar
  16. Darak S, Hutten I, Kulkarni S, Kulkarni V, Janssen F. Occurrence of Pregnancies among HIV Infected Indian Women: Does Knoledge about HIV Status Make a Difference? International Journal of Population Research. 2015: 1-7.
    DOI  |   Google Scholar
  17. Wang N, Yuan Z, Niu W, Li Q, Guo J. Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine. J Chem Technol Biotechnol. 2017; 92(3): 455-462.
    DOI  |   Google Scholar
  18. Ashkenazi A, Salvesen G. Regulated cell death: signaling and mechanisms. Annu Rev Cell Dev Biol. 2014; 30: 337–356.
    DOI  |   Google Scholar
  19. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(04): 495–516.
    DOI  |   Google Scholar
  20. Lee GQ, Dong W, Mo T, Knapp DJ, Brumme CJ, Woods CK, et al. Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapy. PLoS One. 2014; 9: e99000.
    DOI  |   Google Scholar
  21. Mampel MG, Hernandez AS, Moren C. Imbalance in mitochondrial dynamics and apoptosis in pregnancies among HIV-infected women on HAART with obstetric complications. J Antimicrob Chemother. 2017; 72: 2578-258.
     Google Scholar


Most read articles by the same author(s)

<< < 1 2 3 > >>